Document is current
Any future updates will be listed below
-
Authors
Chen, Xinyi https://orcid.org/0000-0002-3365-4284
Situ, Yinglin https://orcid.org/0009-0007-3810-2626
Yang, Yuexuan https://orcid.org/0009-0005-6482-5997
Lyu, Luna
Han, Mengting
Magni, Lorenzo
Fu, Maylin L. https://orcid.org/0000-0003-3749-5003
Deng, Boxiong
Wang, Sui https://orcid.org/0000-0003-1563-9117
Qi, Lei S. https://orcid.org/0000-0002-3965-3223
-
Funding
Funding for this research was provided by:
National Science Foundation (2046650)
U.S. Department of Health & Human Services | National Institutes of Health (R01CA266470; R21AG077193; DP1NS137219)
DH | NIHR | Efficacy and Mechanism Evaluation Programme (R01CA266470)
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 25 February 2026
First Online: 1 April 2026
Competing interests
: X.C. and L.S.Q. are co-inventors of a patent filed by Biohub and Stanford University on related work (WO2025122775). L.S.Q. is a scientific founder of Epicrispr Biotechnologies and an advisor of Enoda Cellworks. The other authors declare no competing interests.
